$IRAA
Iris Acquisition Corp Stock $iraa

$iraa Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-K Financial Statement

#000141057823000725 Filed on April 18, 2023

Income Statement

Concept	2022 Q4	2022	2021
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$1.320M	$1.870M	$2.530M
YoY Change	-8.97%	-26.09%
Operating Profit		-$1.872M	-$2.534M
YoY Change		-26.11%
Interest Expense	$2.870M	$3.070M	$20.00K
YoY Change	28600.0%	15250.0%
% of Operating Profit
Other Income/Expense, Net	-$1.170M	$12.66M	$6.904M
YoY Change	-200.0%	83.4%
Pretax Income	$390.0K	$10.79M	$4.370M
YoY Change	-244.44%	146.91%
Income Tax	$400.0K	$539.8K
% Of Pretax Income	102.56%	5.0%
Net Earnings	-$10.00K	$10.25M	$4.370M
YoY Change	-96.3%	134.56%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	$0.00	$0.30	$0.13
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2022 Q4	2022	2021
SHORT-TERM ASSETS
Cash & Short-Term Investments	$300.0K	$300.0K	$300.0K
YoY Change	0.0%	0.0%
Cash & Equivalents	$280.6K
Short-Term Investments
Other Short-Term Assets	$100.0K	$100.0K	$100.0K
YoY Change	0.0%	0.0%	-66.67%
Inventory
Prepaid Expenses
Receivables
Other Receivables	$1.256K
Total Short-Term Assets	$360.6K	$400.0K	$400.0K
YoY Change	-14.52%	0.0%	33.33%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$15.10M	$15.10M	$276.0M
YoY Change	-94.53%	-94.53%
Other Assets
YoY Change
Total Long-Term Assets	$15.13M	$15.10M	$276.0M
YoY Change	-94.52%	-94.53%
TOTAL ASSETS
Total Short-Term Assets	$360.6K	$400.0K	$400.0K
Total Long-Term Assets	$15.13M	$15.10M	$276.0M
Total Assets	$15.49M	$15.50M	$276.4M
YoY Change	-94.4%	-94.39%	92033.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.500M	$1.500M	$1.100M
YoY Change	36.36%	36.36%
Accrued Expenses	$400.0K	$400.0K	$200.0K
YoY Change	100.0%	100.0%	-33.33%
Deferred Revenue
YoY Change
Short-Term Debt	$1.000M	$1.000M	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.591M	$3.600M	$1.400M
YoY Change	160.17%	157.14%	366.67%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$10.60M	$10.60M	$20.20M
YoY Change	-47.52%	-47.52%
Total Long-Term Liabilities	$10.60M	$10.60M	$20.20M
YoY Change	-47.52%	-47.52%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.591M	$3.600M	$1.400M
Total Long-Term Liabilities	$10.60M	$10.60M	$20.20M
Total Liabilities	$14.19M	$14.20M	$21.60M
YoY Change	-34.2%	-34.26%	7100.0%
SHAREHOLDERS EQUITY
Retained Earnings	-$13.97M
YoY Change	-33.87%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$13.83M	$1.300M	$254.9M
YoY Change
Total Liabilities & Shareholders Equity	$15.49M	$15.50M	$276.4M
YoY Change	-94.4%	-94.39%	92033.33%

Cashflow Statement

Concept	2022 Q4	2022	2021
OPERATING ACTIVITIES
Net Income	-$10.00K	$10.25M	$4.370M
YoY Change	-96.3%	134.56%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$50.00K	-$1.096M	-$1.216M
YoY Change	-80.0%	-9.89%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$264.0M	$264.0M	-$276.0M
YoY Change		-195.64%
Cash From Investing Activities	$264.0M	$264.0M	-$276.0M
YoY Change		-195.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-263.8M	-262.9M	277.6M
YoY Change		-194.73%
NET CHANGE
Cash From Operating Activities	-50.00K	-1.096M	-1.216M
Cash From Investing Activities	264.0M	264.0M	-276.0M
Cash From Financing Activities	-263.8M	-262.9M	277.6M
Net Change In Cash	150.0K	-55.59K	336.2K
YoY Change	-160.0%	-116.53%
FREE CASH FLOW
Cash From Operating Activities	-$50.00K	-$1.096M	-$1.216M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022Q4	iraa	Deferred Offering Costs Noncurrent DeferredOfferingCostsNoncurrent	9660000
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1380389
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021Q1	iraa	Redemption Of Shares Calculated Based On Number Of Business Days Prior To Consummation Of Business Combination RedemptionOfSharesCalculatedBasedOnNumberOfBusinessDaysPriorToConsummationOfBusinessCombination	P2D
CY2021Q1	iraa	Number Of Warrants Issued Per Unit NumberOfWarrantsIssuedPerUnit	0.25
CY2021Q1	iraa	Redemption Period RedemptionPeriod	P30D
CY2021	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2022#FairValueAdjustmentOfWarrants
CY2021Q1	iraa	Threshold Business Days For Redemption Of Public Shares ThresholdBusinessDaysForRedemptionOfPublicShares	P10D
CY2022	dei	Entity Registrant Name EntityRegistrantName	Iris Acquisition Corp
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001831874
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-40167
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-3901431
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	3rd Floor Zephyr House
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	122 Mary Street
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	George Town
CY2022	dei	Entity Address Address Line3 EntityAddressAddressLine3	Grand Cayman
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	KY
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	KY1-1001
CY2022	dei	City Area Code CityAreaCode	971
CY2022	dei	Local Phone Number LocalPhoneNumber	3966949
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	true
CY2022Q2	dei	Entity Public Float EntityPublicFloat	270204000
CY2022	dei	Auditor Firm AuditorFirmId	688
CY2022	dei	Auditor Name AuditorName	Marcum llp
CY2022	dei	Auditor Location AuditorLocation	New York, NY
CY2022Q4	us-gaap	Cash Cash	280640
CY2021Q4	us-gaap	Cash Cash	336228
CY2022Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	1256
CY2021Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	1256
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	78753
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	84438
CY2022Q4	us-gaap	Assets Current AssetsCurrent	360649
CY2021Q4	us-gaap	Assets Current AssetsCurrent	421922
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	15127621
CY2021Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	276016842
CY2022Q4	us-gaap	Assets Assets	15488270
CY2021Q4	us-gaap	Assets Assets	276438764
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	1489462
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	1090389
CY2022Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	75000
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	90000
CY2022Q4	iraa	Franchise Tax Payable FranchiseTaxPayable	447133
CY2021Q4	iraa	Franchise Tax Payable FranchiseTaxPayable	200000
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	539823
CY2022Q4	iraa	Promissory Note Related Party Current PromissoryNoteRelatedPartyCurrent	1040000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3591418
CY2021Q4	iraa	Deferred Offering Costs Noncurrent DeferredOfferingCostsNoncurrent	9660000
CY2022Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares	942646
CY2021Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares	10529510
CY2022Q4	us-gaap	Liabilities Liabilities	14194064
CY2021Q4	us-gaap	Liabilities Liabilities	21569899
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	140000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-13974105
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-21131825
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-13833415
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-21131135
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15488270
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	276438764
CY2022	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	2452467
CY2021	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	2534272
CY2022	iraa	Forgiveness Of Unrelated Vendor Payable ForgivenessOfUnrelatedVendorPayable	579989
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1872478
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-2534272
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-9586864
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-7792536
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	3074691
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	16842
CY2021	iraa	Expensed Offering Costs ExpensedOfferingCosts	606622
CY2021	iraa	Excess Of Fair Value Of Private Placement Warrants ExcessOfFairValueOfPrivatePlacementWarrants	298825
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	12661555
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	6903931
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	10789077
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4369659
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	539823
CY2022	us-gaap	Net Income Loss NetIncomeLoss	10249254
CY2021	us-gaap	Net Income Loss NetIncomeLoss	4369659
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	23698
CY2021	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	25524492
CY2021	us-gaap	Net Income Loss NetIncomeLoss	4369659
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-21131135
CY2022	iraa	Adjustments To Additional Paid In Capital Forgiveness Of Payable Due To Affiliate Of Sponsor AdjustmentsToAdditionalPaidInCapitalForgivenessOfPayableDueToAffiliateOfSponsor	140000
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	3091534
CY2022	us-gaap	Net Income Loss NetIncomeLoss	10249254
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-13833415
CY2022	us-gaap	Profit Loss ProfitLoss	10249254
CY2021	us-gaap	Profit Loss ProfitLoss	4369659
CY2021	iraa	Excess Of Fair Value Of Private Placement Warrants ExcessOfFairValueOfPrivatePlacementWarrants	298825
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-9586864
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-7792536
CY2022	iraa	Forgiveness Of Unrelated Vendor Payable ForgivenessOfUnrelatedVendorPayable	579989
CY2021	iraa	Expensed Offering Costs ExpensedOfferingCosts	606622
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	3074691
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	16842
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-5685
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	84438
CY2021	us-gaap	Increase Decrease In Due From Affiliates Current IncreaseDecreaseInDueFromAffiliatesCurrent	1256
CY2022	iraa	Increase Decrease Franchise Tax Payable IncreaseDecreaseFranchiseTaxPayable	247133
CY2021	iraa	Increase Decrease Franchise Tax Payable IncreaseDecreaseFranchiseTaxPayable	200000
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	539823
CY2022	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	125000
CY2021	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	77500
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	979061
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1126587
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1095588
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1215879
CY2022	us-gaap	Proceeds From Sale Of Loans Held For Investment ProceedsFromSaleOfLoansHeldForInvestment	279091534
CY2022	iraa	Payments For Investment Of Cash In Trust Account PaymentsForInvestmentOfCashInTrustAccount	15127621
CY2021	iraa	Payments For Investment Of Cash In Trust Account PaymentsForInvestmentOfCashInTrustAccount	276000000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	263963913
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-276000000
CY2021	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	275552107
CY2021	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	7520000
CY2021	iraa	Payment Of Underwriter Discount PaymentOfUnderwriterDiscount	5520000
CY2022	iraa	Accretion Of Common Stock Subject To Redemption Value AccretionOfCommonStockSubjectToRedemptionValue	263963913
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	1040000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-262923913
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	277552107
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-55588
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	336228
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	336228
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	280640
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	336228
CY2021	iraa	Initial Fair Value Of Warrant Liabilities InitialFairValueOfWarrantLiabilities	18023221
CY2021	iraa	Deferred Underwriters Discount Payable DeferredUnderwritersDiscountPayable	9660000
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	3091534
CY2021	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	25524492
CY2022	iraa	Forgiveness Of Payable Due To Affiliate Of Sponsor Included In Due To Related Party ForgivenessOfPayableDueToAffiliateOfSponsorIncludedInDueToRelatedParty	140000
CY2021Q1	iraa	Transaction Costs TransactionCosts	15627893
CY2021Q1	iraa	Sale Of Stock Underwriting Discount SaleOfStockUnderwritingDiscount	5520000
CY2021Q1	iraa	Deferred Offering Costs Noncurrent DeferredOfferingCostsNoncurrent	9660000
CY2021Q1	iraa	Sale Of Stock Other Offering Costs SaleOfStockOtherOfferingCosts	447893
CY2021Q1	iraa	Transaction Costs Allocated To Warrant Liability TransactionCostsAllocatedToWarrantLiability	606622
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	15021271
CY2021Q1	iraa	Percentage Obligation To Redeem Public Shares If Entity Does Not Complete Business Combination PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination	1
CY2021Q1	iraa	Minimum Net Tangible Assets Upon Consummation Of Business Combination MinimumNetTangibleAssetsUponConsummationOfBusinessCombination	5000001
CY2021Q1	iraa	Maximum Net Interest To Pay Dissolution Expenses MaximumNetInterestToPayDissolutionExpenses	100000
CY2022Q4	iraa	Working Capital WorkingCapital	2783636
CY2022Q4	iraa	Franchise Tax Payable FranchiseTaxPayable	447133
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</p>
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	280640
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	336228
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 8pt 0pt;"><b style="font-weight:bold;">Concentration of Credit Risk</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 8pt 0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the federal depository insurance coverage of $250,000. As of December 31, 2022 and December 31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</p>
CY2022	iraa	Forgiveness Of Outstanding Vendor Payable ForgivenessOfOutstandingVendorPayable	829989
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	250000
CY2022	iraa	Forgiveness Of Unrelated Vendor Payable ForgivenessOfUnrelatedVendorPayable	579989
CY2021	iraa	Increase Decrease In Valuation Allowance IncreaseDecreaseInValuationAllowance	335341
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	14437500
CY2022	iraa	Transaction Costs Allocated To Warrant Liability TransactionCostsAllocatedToWarrantLiability	606622
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2021Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2021Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	539823
CY2022Q4	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	287359
CY2021Q4	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	335341
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2022	iraa	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrants Liability Percent EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantsLiabilityPercent	0.1866
CY2021	iraa	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrants Liability Percent EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantsLiabilityPercent	0.3745
CY2021	iraa	Effective Income Tax Rate Reconciliation Excess Fair Value Warrants Percent EffectiveIncomeTaxRateReconciliationExcessFairValueWarrantsPercent	0.0144
CY2021	iraa	Schedule Of Common Stock Reflected On Balance Sheet Are Reconciled ScheduleOfCommonStockReflectedOnBalanceSheetAreReconciled	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">As of December 31, 2022 and December 31, 2021, the common stock reflected on the balance sheets are reconciled in the following table:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:12pt;visibility:hidden;"></span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:81.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:81.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Gross proceeds from IPO</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 276,000,000</p></td></tr><tr><td style="vertical-align:bottom;width:81.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Less:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td></tr><tr><td style="vertical-align:bottom;width:81.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Proceeds allocated to Public Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,503,221)</p></td></tr><tr><td style="vertical-align:bottom;width:81.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Common stock issuance costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (15,021,271)</p></td></tr><tr><td style="vertical-align:bottom;width:81.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Plus:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td></tr><tr><td style="vertical-align:bottom;width:81.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Accretion of carrying value to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 25,524,492</p></td></tr><tr><td style="vertical-align:bottom;width:81.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td></tr><tr><td style="vertical-align:bottom;width:81.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Class A common stock subject to possible redemption as December 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 276,000,000</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:81.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Plus: Remeasurement of carrying value to redemption value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,091,534</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:81.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Less: Shares redeemed in December 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (263,963,913)</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:81.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Class A common stock subject to possible redemption as December 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.91%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 15,127,621</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:12pt;visibility:hidden;"></span></p>
CY2021	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock	276000000
CY2021	iraa	Temporary Equity Proceeds Allocated To Warrants TemporaryEquityProceedsAllocatedToWarrants	-10503221
CY2021	iraa	Temporary Equity Issuance Costs TemporaryEquityIssuanceCosts	-15021271
CY2021	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	25524492
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	3091534
CY2022	iraa	Temporary Equity Stock Redeemed Or Called During Period Value TemporaryEquityStockRedeemedOrCalledDuringPeriodValue	-263963913
CY2021Q1	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2022	iraa	Underwriting Discount As Percentage Of Gross Proceeds From Initial Public Offering UnderwritingDiscountAsPercentageOfGrossProceedsFromInitialPublicOffering	0.02
CY2022Q4	iraa	Underwriting Costs Noncurrent UnderwritingCostsNoncurrent	5520000
CY2022	iraa	Deferred Underwriting Discount As Percentage Of Gross Proceeds From Initial Public Offering DeferredUnderwritingDiscountAsPercentageOfGrossProceedsFromInitialPublicOffering	0.035
CY2022Q4	iraa	Deferred Offering Costs Noncurrent DeferredOfferingCostsNoncurrent	9660000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q4	iraa	Common Stock Number Of Votes Per Share CommonStockNumberOfVotesPerShare	1
CY2022Q4	iraa	Deferred Tax Assets Capitalized Start Up And Organization Costs DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts	637807
CY2021Q4	iraa	Deferred Tax Assets Capitalized Start Up And Organization Costs DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts	296479
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	53969
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	637807
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	350448
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	637807
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	350448
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	539823
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-287359
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-335341
CY2022	iraa	Increase Decrease In Valuation Allowance IncreaseDecreaseInValuationAllowance	287359
CY2021	iraa	Effective Income Tax Rate Reconciliation Warrant Transaction Costs Percent EffectiveIncomeTaxRateReconciliationWarrantTransactionCostsPercent	0.0292
CY2021	iraa	Effective Income Tax Rate Reconciliation Acquisitions Facilitative Expenses Percent EffectiveIncomeTaxRateReconciliationAcquisitionsFacilitativeExpensesPercent	0.0442
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.0266
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.0767
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0500
CY2022Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares	942646
CY2021Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares	10529510
CY2021	iraa	Excess Of Fair Value Of Private Placement Warrants ExcessOfFairValueOfPrivatePlacementWarrants	298825

Files In Submission

Name	View Source	Status
0001410578-23-000725-index-headers.html	Edgar Link	pending
0001410578-23-000725-index.html	Edgar Link	pending
0001410578-23-000725.txt	Edgar Link	pending
0001410578-23-000725-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
iraa-20221231.xsd	Edgar Link	pending
iraa-20221231x10k.htm	Edgar Link	pending
iraa-20221231xex10d18.htm	Edgar Link	pending
iraa-20221231xex10d19.htm	Edgar Link	pending
iraa-20221231xex10d20.htm	Edgar Link	pending
iraa-20221231xex31d1.htm	Edgar Link	pending
iraa-20221231xex31d2.htm	Edgar Link	pending
iraa-20221231xex32d1.htm	Edgar Link	pending
iraa-20221231xex32d2.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
iraa-20221231_def.xml	Edgar Link	unprocessable
iraa-20221231_lab.xml	Edgar Link	unprocessable
iraa-20221231_pre.xml	Edgar Link	unprocessable
iraa-20221231x10k_htm.xml	Edgar Link	completed
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
iraa-20221231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IRAA
Iris Acquisition Corp Stock $iraa

2022 Q4 Form 10-K Financial Statement

#000141057823000725 Filed on April 18, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IRAA Iris Acquisition Corp Stock $iraa

2022 Q4 Form 10-K Financial Statement

#000141057823000725 Filed on April 18, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IRAA
Iris Acquisition Corp Stock $iraa